Abstract
Abstract
Purpose
To assess the association between nut and seed consumption, both combined and separately, and metabolic syndrome and its components, including fasting glucose, triglycerides, high-density lipoprotein (HDL) cholesterol, central obesity, and blood pressure.
Methods
This cross-sectional analysis used data from 22,687 adults (aged ≥ 18 years) involved in seven cycles (2005–2018) of the National Health and Nutrition Examination Survey (NHANES). Habitual nut and seed intakes were estimated by the Multiple Source Method using data from two 24-h dietary recalls. Metabolic syndrome was ascertained using biochemical data and self-reported medication use. Sex-specific effect estimates were obtained using logistic and linear regressions adjusting for lifestyle and socioeconomic confounders.
Results
Compared to non-consumers, female, but not male, habitual consumers of either nuts or seeds had lower odds of having metabolic syndrome (OR: 0.83, 95% CI 0.71, 0.97). Both nut intake alone and seed intake alone were inversely associated with high fasting glucose and low HDL-cholesterol in females compared to non-consumers. When restricted to habitual consumers only, the combined intake of nuts and seeds at 6 g/day was associated with the lowest triglycerides and highest HDL-cholesterol in females. Combined consumption of nuts and seeds up to one ounce-equivalent (15 g) per day, but not in higher intake levels, was inversely associated with metabolic syndrome, high fasting glucose, central obesity, and low HDL-cholesterol in females.
Conclusions
Nut and seed consumption, both separately or combined, below 15 g/day was inversely associated with metabolic syndrome and its component conditions in females but not males.
Publisher
Springer Science and Business Media LLC
Subject
Nutrition and Dietetics,Medicine (miscellaneous)
Reference53 articles.
1. Alberti KGMM, Eckel Robert H, Grundy Scott M, Zimmet Paul Z, Cleeman James I, Donato Karen A, Fruchart J-C, James WPT, Loria Catherine M, Smith Sidney C (2009) Harmonizing the metabolic syndrome. Circulation 120(16):1640–1645. https://doi.org/10.1161/CIRCULATIONAHA.109.192644
2. Hirode G, Wong RJ (2020) Trends in the Prevalence of Metabolic Syndrome in the United States, 2011–2016. JAMA 323(24):2526–2528. https://doi.org/10.1001/jama.2020.4501
3. Tanamas SK, Magliano DJ, Lynch B, Sethi P, Willenberg L, Polkinghorne KR, Chadban S, Dunstan D, Shaw JE (2013). AusDiab 2012. The Australian Diabetes, Obesity and Lifestyle Study. Baker IDI Heart and Diabetes Institute, Melbourne. Available at https://www.baker.edu.au/-/media/documents/impact/ausdiab/reports/ausdiabreport-2012.pdf?la=en
4. Scuteri A, Laurent S, Cucca F, Cockcroft J, Cunha PG, Mañas LR, Raso FUM, Muiesan ML, Ryliškytė L, Rietzschel E, Strait J, Vlachopoulos C, Völzke H, Lakatta EG, Nilsson PM, for the Metabolic S, Arteries Research C (2015) Metabolic syndrome across Europe: different clusters of risk factors. Eur J Prevent Cardiol 22(4):486–491. https://doi.org/10.1177/2047487314525529
5. Liu B, Chen G, Zhao R, Huang D, Tao L (2021) Temporal trends in the prevalence of metabolic syndrome among middle-aged and elderly adults from 2011 to 2015 in China: the China health and retirement longitudinal study (CHARLS). BMC Public Health 21(1):1045. https://doi.org/10.1186/s12889-021-11042-x
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献